Title: Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones.
Journal: Biochemical pharmacology 20120615
Title: Bis{μ-2-[bis-(pyridin-2-yl)methyl-idene]hydrazinecarbothio-amidato}bis-[bromido-copper(II)] methanol disolvate.
Journal: Acta crystallographica. Section E, Structure reports online 20120301
Title: Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
Journal: Cancer research 20110901
Title: Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9.
Journal: Molecular pharmacology 20110101
Title: The medicinal chemistry of novel iron chelators for the treatment of cancer.
Journal: Current topics in medicinal chemistry 20110101
Title: Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.
Journal: Biochimica et biophysica acta 20090701
Title: 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
Journal: Journal of medicinal chemistry 20090312
Title: Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity.
Journal: Journal of medicinal chemistry 20090122
Title: Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
Journal: Journal of medicinal chemistry 20070726
Title: Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.
Journal: Chemical research in toxicology 20070501
Title: Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.
Journal: Journal of medicinal chemistry 20061102
